{
    "nctId": "NCT04986579",
    "briefTitle": "Scalp Cooling in MBC",
    "officialTitle": "Assessing the Impact of Scalp Cooling in With Metastatic Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Metastatic Breast Cancer, Chemotherapy-induced Alopecia",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Hair Loss Rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Men and women with a diagnosis of metastatic invasive breast cancer with a ECOG PS\u22642\n* Participant is \u2265 18 years old.\n* Hair present at baseline.\n* One of the following full dose chemotherapy regimens must be planned for at least 4 cycles:\n\n  * Sacituzumab govitecan (IMMU-132) 10 mg/kg administered intravenously on days 1 and 8 of each 21-day cycle\n  * Trastuzumab deruxtecan 5.4 mg/kg administered intravenously once every 3 weeks\n  * Eribulin 1.4 mg/m2 administered intravenously on days 1 and 8 of each 21-day cycle\n* The Paxman Scalp Cooling System must be initiated with the first dose of therapy in participants that elect to participate in the scalp cooling group.\n\nExclusion Criteria:\n\n* Known hematological malignancies (i.e. leukemia or lymphoma)\n* Known scalp metastases.\n* Baseline alopecia (defined CTCAE 5.0 grade \\> 0, see Appendix B)\n* Subjects with cold agglutinin disease or cold urticaria.\n* Subjects who are scheduled for bone marrow ablation chemotherapy.\n* Personal history of migraines, cluster or tension headaches as defined as actual medical diagnosis by a physician and/ or prescribed medications. If personal history of migraines was related to a past medical problem that is now resolved, the subject may go on study at the discretion of the Principal Investigator.\n* Subjects who have lichen planus or lupus.\n* Participants who are receiving any additional anti-cancer agents",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}